Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bjarnason

Showing results (111-120 of 171) with videos related to

Pageof 18
Sort By:
Gut|March 1, 1996
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteriaA Macpherson, U Y Khoo, I Forgacs, et al.
Arthritis and Rheumatism|August 1, 1994
Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugsJ Hayllar, T Smith, A Macpherson, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2015
Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?P Pavlidis, N Powell, R P Vincent, et al.
Arthritis and Rheumatism|December 1, 1996
Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylationT Mahmud, S S Rafi, D L Scott, et al.
Scandinavian Journal of Gastroenterology|July 1, 1991
The effect of polyacrylic acid polymers on small-intestinal function and permeability changes caused by indomethacinI Bjarnason, P Smethurst, A J Levi, et al.
Gut|November 1, 1985
Intestinal permeability in patients with coeliac disease and dermatitis herpetiformisI Bjarnason, M N Marsh, A Price, et al.
BMC Gastroenterology|April 19, 2002
2, 4-diamino-6- hydroxy pyrimidine inhibits NSAIDs induced nitrosyl-complex EPR signals and ulcer in rat jejunumS Somasundaram, R Simpson, S Rafi, et al.
Arthritis and Rheumatism|January 5, 2002
Inflammatory bowel disease and spondylarthropathyS Smale, R S Natt, T R Orchard, et al.
Gut|September 1, 1996
Evaluation of differential disaccharide excretion in urine for non-invasive investigation of altered intestinal disaccharidase activity caused by alpha-glucosidase inhibition, primary hypolactasia, and coeliac diseaseI Bjarnason, R Batt, S Catt, et al.
Gut|February 1, 1997
Reduced bone density in patients with inflammatory bowel diseaseI Bjarnason, A Macpherson, C Mackintosh, et al.
Pageof 18

Showing results (111-120 of 171) with videos related to

Sort By:
Pageof 18
Gut|March 1, 1996
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteriaA Macpherson, U Y Khoo, I Forgacs, et al.
Arthritis and Rheumatism|August 1, 1994
Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugsJ Hayllar, T Smith, A Macpherson, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2015
Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?P Pavlidis, N Powell, R P Vincent, et al.
Arthritis and Rheumatism|December 1, 1996
Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylationT Mahmud, S S Rafi, D L Scott, et al.
Scandinavian Journal of Gastroenterology|July 1, 1991
The effect of polyacrylic acid polymers on small-intestinal function and permeability changes caused by indomethacinI Bjarnason, P Smethurst, A J Levi, et al.
Gut|November 1, 1985
Intestinal permeability in patients with coeliac disease and dermatitis herpetiformisI Bjarnason, M N Marsh, A Price, et al.
BMC Gastroenterology|April 19, 2002
2, 4-diamino-6- hydroxy pyrimidine inhibits NSAIDs induced nitrosyl-complex EPR signals and ulcer in rat jejunumS Somasundaram, R Simpson, S Rafi, et al.
Arthritis and Rheumatism|January 5, 2002
Inflammatory bowel disease and spondylarthropathyS Smale, R S Natt, T R Orchard, et al.
Gut|September 1, 1996
Evaluation of differential disaccharide excretion in urine for non-invasive investigation of altered intestinal disaccharidase activity caused by alpha-glucosidase inhibition, primary hypolactasia, and coeliac diseaseI Bjarnason, R Batt, S Catt, et al.
Gut|February 1, 1997
Reduced bone density in patients with inflammatory bowel diseaseI Bjarnason, A Macpherson, C Mackintosh, et al.
Pageof 18